Global Glucosylceramidase Market Growth 2025-2031

October 2025 | 96 pages | ID: GF069C68D520EN
LP Information

Abstracts

The global Glucosylceramidase market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Glucosylceramidase is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Glucosylceramidase is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Glucosylceramidase is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Glucosylceramidase players cover Amicus Therapeutics, Inc., Bioorganic Research and Services S.A., greenovation Biotech GmbH, JCR Pharmaceuticals Co., Ltd., Pharming Group N.V., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Glucosylceramidase Industry Forecast? looks at past sales and reviews total world Glucosylceramidase sales in 2024, providing a comprehensive analysis by region and market sector of projected Glucosylceramidase sales for 2025 through 2031. With Glucosylceramidase sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glucosylceramidase industry.

This Insight Report provides a comprehensive analysis of the global Glucosylceramidase landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glucosylceramidase portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Glucosylceramidase market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glucosylceramidase and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glucosylceramidase.

This report presents a comprehensive overview, market shares, and growth opportunities of Glucosylceramidase market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• AVRRD-02
• LTI-291
• NCGC-607
• Pcgin
• Others

Segmentation by Application:

• Genetic Disorders
• Gaucher Disease
• Parkinson's Disease
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Amicus Therapeutics, Inc.
• Bioorganic Research and Services S.A.
• greenovation Biotech GmbH
• JCR Pharmaceuticals Co., Ltd.
• Pharming Group N.V.
• Protalix BioTherapeutics, Inc.
• Takeda
• The International Biotechnology Center (IBC) Generium

Key Questions Addressed in this Report

What is the 10-year outlook for the global Glucosylceramidase market?
What factors are driving Glucosylceramidase market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Glucosylceramidase market opportunities vary by end market size?
How does Glucosylceramidase break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Glucosylceramidase Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Glucosylceramidase by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Glucosylceramidase by Country/Region, 2020, 2024 & 2031
2.2 Glucosylceramidase Segment by Type
  2.2.1 AVRRD-02
  2.2.2 LTI-291
  2.2.3 NCGC-607
  2.2.4 Pcgin
  2.2.5 Others
2.3 Glucosylceramidase Sales by Type
  2.3.1 Global Glucosylceramidase Sales Market Share by Type (2020-2025)
  2.3.2 Global Glucosylceramidase Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Glucosylceramidase Sale Price by Type (2020-2025)
2.4 Glucosylceramidase Segment by Application
  2.4.1 Genetic Disorders
  2.4.2 Gaucher Disease
  2.4.3 Parkinson's Disease
  2.4.4 Others
2.5 Glucosylceramidase Sales by Application
  2.5.1 Global Glucosylceramidase Sale Market Share by Application (2020-2025)
  2.5.2 Global Glucosylceramidase Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Glucosylceramidase Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Glucosylceramidase Breakdown Data by Company
  3.1.1 Global Glucosylceramidase Annual Sales by Company (2020-2025)
  3.1.2 Global Glucosylceramidase Sales Market Share by Company (2020-2025)
3.2 Global Glucosylceramidase Annual Revenue by Company (2020-2025)
  3.2.1 Global Glucosylceramidase Revenue by Company (2020-2025)
  3.2.2 Global Glucosylceramidase Revenue Market Share by Company (2020-2025)
3.3 Global Glucosylceramidase Sale Price by Company
3.4 Key Manufacturers Glucosylceramidase Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Glucosylceramidase Product Location Distribution
  3.4.2 Players Glucosylceramidase Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR GLUCOSYLCERAMIDASE BY GEOGRAPHIC REGION

4.1 World Historic Glucosylceramidase Market Size by Geographic Region (2020-2025)
  4.1.1 Global Glucosylceramidase Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Glucosylceramidase Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Glucosylceramidase Market Size by Country/Region (2020-2025)
  4.2.1 Global Glucosylceramidase Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Glucosylceramidase Annual Revenue by Country/Region (2020-2025)
4.3 Americas Glucosylceramidase Sales Growth
4.4 APAC Glucosylceramidase Sales Growth
4.5 Europe Glucosylceramidase Sales Growth
4.6 Middle East & Africa Glucosylceramidase Sales Growth

5 AMERICAS

5.1 Americas Glucosylceramidase Sales by Country
  5.1.1 Americas Glucosylceramidase Sales by Country (2020-2025)
  5.1.2 Americas Glucosylceramidase Revenue by Country (2020-2025)
5.2 Americas Glucosylceramidase Sales by Type (2020-2025)
5.3 Americas Glucosylceramidase Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Glucosylceramidase Sales by Region
  6.1.1 APAC Glucosylceramidase Sales by Region (2020-2025)
  6.1.2 APAC Glucosylceramidase Revenue by Region (2020-2025)
6.2 APAC Glucosylceramidase Sales by Type (2020-2025)
6.3 APAC Glucosylceramidase Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Glucosylceramidase by Country
  7.1.1 Europe Glucosylceramidase Sales by Country (2020-2025)
  7.1.2 Europe Glucosylceramidase Revenue by Country (2020-2025)
7.2 Europe Glucosylceramidase Sales by Type (2020-2025)
7.3 Europe Glucosylceramidase Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Glucosylceramidase by Country
  8.1.1 Middle East & Africa Glucosylceramidase Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Glucosylceramidase Revenue by Country (2020-2025)
8.2 Middle East & Africa Glucosylceramidase Sales by Type (2020-2025)
8.3 Middle East & Africa Glucosylceramidase Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Glucosylceramidase
10.3 Manufacturing Process Analysis of Glucosylceramidase
10.4 Industry Chain Structure of Glucosylceramidase

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Glucosylceramidase Distributors
11.3 Glucosylceramidase Customer

12 WORLD FORECAST REVIEW FOR GLUCOSYLCERAMIDASE BY GEOGRAPHIC REGION

12.1 Global Glucosylceramidase Market Size Forecast by Region
  12.1.1 Global Glucosylceramidase Forecast by Region (2026-2031)
  12.1.2 Global Glucosylceramidase Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Glucosylceramidase Forecast by Type (2026-2031)
12.7 Global Glucosylceramidase Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Amicus Therapeutics, Inc.
  13.1.1 Amicus Therapeutics, Inc. Company Information
  13.1.2 Amicus Therapeutics, Inc. Glucosylceramidase Product Portfolios and Specifications
  13.1.3 Amicus Therapeutics, Inc. Glucosylceramidase Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Amicus Therapeutics, Inc. Main Business Overview
  13.1.5 Amicus Therapeutics, Inc. Latest Developments
13.2 Bioorganic Research and Services S.A.
  13.2.1 Bioorganic Research and Services S.A. Company Information
  13.2.2 Bioorganic Research and Services S.A. Glucosylceramidase Product Portfolios and Specifications
  13.2.3 Bioorganic Research and Services S.A. Glucosylceramidase Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Bioorganic Research and Services S.A. Main Business Overview
  13.2.5 Bioorganic Research and Services S.A. Latest Developments
13.3 greenovation Biotech GmbH
  13.3.1 greenovation Biotech GmbH Company Information
  13.3.2 greenovation Biotech GmbH Glucosylceramidase Product Portfolios and Specifications
  13.3.3 greenovation Biotech GmbH Glucosylceramidase Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 greenovation Biotech GmbH Main Business Overview
  13.3.5 greenovation Biotech GmbH Latest Developments
13.4 JCR Pharmaceuticals Co., Ltd.
  13.4.1 JCR Pharmaceuticals Co., Ltd. Company Information
  13.4.2 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Product Portfolios and Specifications
  13.4.3 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 JCR Pharmaceuticals Co., Ltd. Main Business Overview
  13.4.5 JCR Pharmaceuticals Co., Ltd. Latest Developments
13.5 Pharming Group N.V.
  13.5.1 Pharming Group N.V. Company Information
  13.5.2 Pharming Group N.V. Glucosylceramidase Product Portfolios and Specifications
  13.5.3 Pharming Group N.V. Glucosylceramidase Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Pharming Group N.V. Main Business Overview
  13.5.5 Pharming Group N.V. Latest Developments
13.6 Protalix BioTherapeutics, Inc.
  13.6.1 Protalix BioTherapeutics, Inc. Company Information
  13.6.2 Protalix BioTherapeutics, Inc. Glucosylceramidase Product Portfolios and Specifications
  13.6.3 Protalix BioTherapeutics, Inc. Glucosylceramidase Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Protalix BioTherapeutics, Inc. Main Business Overview
  13.6.5 Protalix BioTherapeutics, Inc. Latest Developments
13.7 Takeda
  13.7.1 Takeda Company Information
  13.7.2 Takeda Glucosylceramidase Product Portfolios and Specifications
  13.7.3 Takeda Glucosylceramidase Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Takeda Main Business Overview
  13.7.5 Takeda Latest Developments
13.8 The International Biotechnology Center (IBC) Generium
  13.8.1 The International Biotechnology Center (IBC) Generium Company Information
  13.8.2 The International Biotechnology Center (IBC) Generium Glucosylceramidase Product Portfolios and Specifications
  13.8.3 The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 The International Biotechnology Center (IBC) Generium Main Business Overview
  13.8.5 The International Biotechnology Center (IBC) Generium Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Glucosylceramidase Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Glucosylceramidase Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of AVRRD-02
Table 4. Major Players of LTI-291
Table 5. Major Players of NCGC-607
Table 6. Major Players of Pcgin
Table 7. Major Players of Others
Table 8. Global Glucosylceramidase Sales by Type (2020-2025) & (K Pcs)
Table 9. Global Glucosylceramidase Sales Market Share by Type (2020-2025)
Table 10. Global Glucosylceramidase Revenue by Type (2020-2025) & ($ million)
Table 11. Global Glucosylceramidase Revenue Market Share by Type (2020-2025)
Table 12. Global Glucosylceramidase Sale Price by Type (2020-2025) & (USD/Pcs)
Table 13. Global Glucosylceramidase Sale by Application (2020-2025) & (K Pcs)
Table 14. Global Glucosylceramidase Sale Market Share by Application (2020-2025)
Table 15. Global Glucosylceramidase Revenue by Application (2020-2025) & ($ million)
Table 16. Global Glucosylceramidase Revenue Market Share by Application (2020-2025)
Table 17. Global Glucosylceramidase Sale Price by Application (2020-2025) & (USD/Pcs)
Table 18. Global Glucosylceramidase Sales by Company (2020-2025) & (K Pcs)
Table 19. Global Glucosylceramidase Sales Market Share by Company (2020-2025)
Table 20. Global Glucosylceramidase Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Glucosylceramidase Revenue Market Share by Company (2020-2025)
Table 22. Global Glucosylceramidase Sale Price by Company (2020-2025) & (USD/Pcs)
Table 23. Key Manufacturers Glucosylceramidase Producing Area Distribution and Sales Area
Table 24. Players Glucosylceramidase Products Offered
Table 25. Glucosylceramidase Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Glucosylceramidase Sales by Geographic Region (2020-2025) & (K Pcs)
Table 29. Global Glucosylceramidase Sales Market Share Geographic Region (2020-2025)
Table 30. Global Glucosylceramidase Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Glucosylceramidase Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Glucosylceramidase Sales by Country/Region (2020-2025) & (K Pcs)
Table 33. Global Glucosylceramidase Sales Market Share by Country/Region (2020-2025)
Table 34. Global Glucosylceramidase Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Glucosylceramidase Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Glucosylceramidase Sales by Country (2020-2025) & (K Pcs)
Table 37. Americas Glucosylceramidase Sales Market Share by Country (2020-2025)
Table 38. Americas Glucosylceramidase Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Glucosylceramidase Sales by Type (2020-2025) & (K Pcs)
Table 40. Americas Glucosylceramidase Sales by Application (2020-2025) & (K Pcs)
Table 41. APAC Glucosylceramidase Sales by Region (2020-2025) & (K Pcs)
Table 42. APAC Glucosylceramidase Sales Market Share by Region (2020-2025)
Table 43. APAC Glucosylceramidase Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Glucosylceramidase Sales by Type (2020-2025) & (K Pcs)
Table 45. APAC Glucosylceramidase Sales by Application (2020-2025) & (K Pcs)
Table 46. Europe Glucosylceramidase Sales by Country (2020-2025) & (K Pcs)
Table 47. Europe Glucosylceramidase Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Glucosylceramidase Sales by Type (2020-2025) & (K Pcs)
Table 49. Europe Glucosylceramidase Sales by Application (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Glucosylceramidase Sales by Country (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Glucosylceramidase Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Glucosylceramidase Sales by Type (2020-2025) & (K Pcs)
Table 53. Middle East & Africa Glucosylceramidase Sales by Application (2020-2025) & (K Pcs)
Table 54. Key Market Drivers & Growth Opportunities of Glucosylceramidase
Table 55. Key Market Challenges & Risks of Glucosylceramidase
Table 56. Key Industry Trends of Glucosylceramidase
Table 57. Glucosylceramidase Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Glucosylceramidase Distributors List
Table 60. Glucosylceramidase Customer List
Table 61. Global Glucosylceramidase Sales Forecast by Region (2026-2031) & (K Pcs)
Table 62. Global Glucosylceramidase Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Glucosylceramidase Sales Forecast by Country (2026-2031) & (K Pcs)
Table 64. Americas Glucosylceramidase Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Glucosylceramidase Sales Forecast by Region (2026-2031) & (K Pcs)
Table 66. APAC Glucosylceramidase Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Glucosylceramidase Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Europe Glucosylceramidase Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Glucosylceramidase Sales Forecast by Country (2026-2031) & (K Pcs)
Table 70. Middle East & Africa Glucosylceramidase Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Glucosylceramidase Sales Forecast by Type (2026-2031) & (K Pcs)
Table 72. Global Glucosylceramidase Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Glucosylceramidase Sales Forecast by Application (2026-2031) & (K Pcs)
Table 74. Global Glucosylceramidase Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Amicus Therapeutics, Inc. Basic Information, Glucosylceramidase Manufacturing Base, Sales Area and Its Competitors
Table 76. Amicus Therapeutics, Inc. Glucosylceramidase Product Portfolios and Specifications
Table 77. Amicus Therapeutics, Inc. Glucosylceramidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Amicus Therapeutics, Inc. Main Business
Table 79. Amicus Therapeutics, Inc. Latest Developments
Table 80. Bioorganic Research and Services S.A. Basic Information, Glucosylceramidase Manufacturing Base, Sales Area and Its Competitors
Table 81. Bioorganic Research and Services S.A. Glucosylceramidase Product Portfolios and Specifications
Table 82. Bioorganic Research and Services S.A. Glucosylceramidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Bioorganic Research and Services S.A. Main Business
Table 84. Bioorganic Research and Services S.A. Latest Developments
Table 85. greenovation Biotech GmbH Basic Information, Glucosylceramidase Manufacturing Base, Sales Area and Its Competitors
Table 86. greenovation Biotech GmbH Glucosylceramidase Product Portfolios and Specifications
Table 87. greenovation Biotech GmbH Glucosylceramidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. greenovation Biotech GmbH Main Business
Table 89. greenovation Biotech GmbH Latest Developments
Table 90. JCR Pharmaceuticals Co., Ltd. Basic Information, Glucosylceramidase Manufacturing Base, Sales Area and Its Competitors
Table 91. JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Product Portfolios and Specifications
Table 92. JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. JCR Pharmaceuticals Co., Ltd. Main Business
Table 94. JCR Pharmaceuticals Co., Ltd. Latest Developments
Table 95. Pharming Group N.V. Basic Information, Glucosylceramidase Manufacturing Base, Sales Area and Its Competitors
Table 96. Pharming Group N.V. Glucosylceramidase Product Portfolios and Specifications
Table 97. Pharming Group N.V. Glucosylceramidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Pharming Group N.V. Main Business
Table 99. Pharming Group N.V. Latest Developments
Table 100. Protalix BioTherapeutics, Inc. Basic Information, Glucosylceramidase Manufacturing Base, Sales Area and Its Competitors
Table 101. Protalix BioTherapeutics, Inc. Glucosylceramidase Product Portfolios and Specifications
Table 102. Protalix BioTherapeutics, Inc. Glucosylceramidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Protalix BioTherapeutics, Inc. Main Business
Table 104. Protalix BioTherapeutics, Inc. Latest Developments
Table 105. Takeda Basic Information, Glucosylceramidase Manufacturing Base, Sales Area and Its Competitors
Table 106. Takeda Glucosylceramidase Product Portfolios and Specifications
Table 107. Takeda Glucosylceramidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Takeda Main Business
Table 109. Takeda Latest Developments
Table 110. The International Biotechnology Center (IBC) Generium Basic Information, Glucosylceramidase Manufacturing Base, Sales Area and Its Competitors
Table 111. The International Biotechnology Center (IBC) Generium Glucosylceramidase Product Portfolios and Specifications
Table 112. The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. The International Biotechnology Center (IBC) Generium Main Business
Table 114. The International Biotechnology Center (IBC) Generium Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Glucosylceramidase
Figure 2. Glucosylceramidase Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Glucosylceramidase Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Glucosylceramidase Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Glucosylceramidase Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Glucosylceramidase Sales Market Share by Country/Region (2024)
Figure 10. Glucosylceramidase Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of AVRRD-02
Figure 12. Product Picture of LTI-291
Figure 13. Product Picture of NCGC-607
Figure 14. Product Picture of Pcgin
Figure 15. Product Picture of Others
Figure 16. Global Glucosylceramidase Sales Market Share by Type in 2025
Figure 17. Global Glucosylceramidase Revenue Market Share by Type (2020-2025)
Figure 18. Glucosylceramidase Consumed in Genetic Disorders
Figure 19. Global Glucosylceramidase Market: Genetic Disorders (2020-2025) & (K Pcs)
Figure 20. Glucosylceramidase Consumed in Gaucher Disease
Figure 21. Global Glucosylceramidase Market: Gaucher Disease (2020-2025) & (K Pcs)
Figure 22. Glucosylceramidase Consumed in Parkinson's Disease
Figure 23. Global Glucosylceramidase Market: Parkinson's Disease (2020-2025) & (K Pcs)
Figure 24. Glucosylceramidase Consumed in Others
Figure 25. Global Glucosylceramidase Market: Others (2020-2025) & (K Pcs)
Figure 26. Global Glucosylceramidase Sale Market Share by Application (2024)
Figure 27. Global Glucosylceramidase Revenue Market Share by Application in 2025
Figure 28. Glucosylceramidase Sales by Company in 2025 (K Pcs)
Figure 29. Global Glucosylceramidase Sales Market Share by Company in 2025
Figure 30. Glucosylceramidase Revenue by Company in 2025 ($ millions)
Figure 31. Global Glucosylceramidase Revenue Market Share by Company in 2025
Figure 32. Global Glucosylceramidase Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Glucosylceramidase Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Glucosylceramidase Sales 2020-2025 (K Pcs)
Figure 35. Americas Glucosylceramidase Revenue 2020-2025 ($ millions)
Figure 36. APAC Glucosylceramidase Sales 2020-2025 (K Pcs)
Figure 37. APAC Glucosylceramidase Revenue 2020-2025 ($ millions)
Figure 38. Europe Glucosylceramidase Sales 2020-2025 (K Pcs)
Figure 39. Europe Glucosylceramidase Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Glucosylceramidase Sales 2020-2025 (K Pcs)
Figure 41. Middle East & Africa Glucosylceramidase Revenue 2020-2025 ($ millions)
Figure 42. Americas Glucosylceramidase Sales Market Share by Country in 2025
Figure 43. Americas Glucosylceramidase Revenue Market Share by Country (2020-2025)
Figure 44. Americas Glucosylceramidase Sales Market Share by Type (2020-2025)
Figure 45. Americas Glucosylceramidase Sales Market Share by Application (2020-2025)
Figure 46. United States Glucosylceramidase Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Glucosylceramidase Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Glucosylceramidase Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Glucosylceramidase Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Glucosylceramidase Sales Market Share by Region in 2025
Figure 51. APAC Glucosylceramidase Revenue Market Share by Region (2020-2025)
Figure 52. APAC Glucosylceramidase Sales Market Share by Type (2020-2025)
Figure 53. APAC Glucosylceramidase Sales Market Share by Application (2020-2025)
Figure 54. China Glucosylceramidase Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Glucosylceramidase Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Glucosylceramidase Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Glucosylceramidase Revenue Growth 2020-2025 ($ millions)
Figure 58. India Glucosylceramidase Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Glucosylceramidase Revenue Growth 2020-2025 ($ millions)
Figure 60. China Taiwan Glucosylceramidase Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Glucosylceramidase Sales Market Share by Country in 2025
Figure 62. Europe Glucosylceramidase Revenue Market Share by Country (2020-2025)
Figure 63. Europe Glucosylceramidase Sales Market Share by Type (2020-2025)
Figure 64. Europe Glucosylceramidase Sales Market Share by Application (2020-2025)
Figure 65. Germany Glucosylceramidase Revenue Growth 2020-2025 ($ millions)
Figure 66. France Glucosylceramidase Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Glucosylceramidase Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Glucosylceramidase Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Glucosylceramidase Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Glucosylceramidase Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Glucosylceramidase Sales Market Share by Type (2020-2025)
Figure 72. Middle East & Africa Glucosylceramidase Sales Market Share by Application (2020-2025)
Figure 73. Egypt Glucosylceramidase Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Glucosylceramidase Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Glucosylceramidase Revenue Growth 2020-2025 ($ millions)
Figure 76. Turkey Glucosylceramidase Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Glucosylceramidase Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Glucosylceramidase in 2025
Figure 79. Manufacturing Process Analysis of Glucosylceramidase
Figure 80. Industry Chain Structure of Glucosylceramidase
Figure 81. Channels of Distribution
Figure 82. Global Glucosylceramidase Sales Market Forecast by Region (2026-2031)
Figure 83. Global Glucosylceramidase Revenue Market Share Forecast by Region (2026-2031)
Figure 84. Global Glucosylceramidase Sales Market Share Forecast by Type (2026-2031)
Figure 85. Global Glucosylceramidase Revenue Market Share Forecast by Type (2026-2031)
Figure 86. Global Glucosylceramidase Sales Market Share Forecast by Application (2026-2031)
Figure 87. Global Glucosylceramidase Revenue Market Share Forecast by Application (2026-2031)